GlassScriptPhysician profile
Jason D Walsh
NPI 1518971282
$57,770.57
in general payments reported to CMS, 2019-2025
28 companies · $3,471 in 2025
The $3,471 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $2,968 · 2021: $1,359 · 2022: $17K · 2023: $4,678 · 2024: $8,585 · 2025: $3,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $3,345 · Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Travel and Lodging | $3,345.15 |
| Food and Beverage | $1,388.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $53,781.70 | 2019-2025 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $1,318.71 | 2025 | Phasix Mesh |
| Davol INC. | $985.32 | 2019-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $639.09 | 2020 | |
| Depuy Synthes Sales INC. | $190.82 | 2020 | |
| Abbvie INC. | $124.90 | 2022-2024 | Dalvance |
| Stryker Corporation | $95.54 | 2019-2022 | |
| Kls-Martin L.P. | $87.97 | 2024 | |
| Kerecis Limited | $73.91 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $62.67 | 2019 | |
| Medtronic Vascular, INC. | $50.51 | 2019 | |
| Pfizer INC. | $47.22 | 2019-2025 | |
| Integra Lifesciences Corporation | $45.97 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $27.12 | 2020 | |
| Novo Nordisk INC | $26.65 | 2022-2024 | Rybelsus, Ozempic |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $26.24 | 2024 | Stravix, Grafix Pl |
| Linvatec Corporation | $22.78 | 2022 | |
| Kci USA, INC. | $18.99 | 2023 | Promogran Prisma, V.A.C.Instill, Activ.A.C. |
| Medtronic, INC. | $18.66 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.19 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.07 | 2023 | |
| Mallinckrodt Hospital Products INC. | $15.69 | 2022 | |
| Biogen, INC. | $15.47 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $14.50 | 2022 | |
| Medline Industries LP | $13.93 | 2022 | |
| Lilly USA, LLC | $13.41 | 2024 | Jardiance |
| Covidien LP | $11.51 | 2020 | |
| Phathom Pharmaceuticals, INC. | $5.03 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.